Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03025542 · ClinicalTrials.gov registry record · Phase 2

A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis

A Phase 2 study of Chronic Plaque Psoriasis, sponsored by UCB Biopharma SRL.

Completed
Registry status
Phase 2
Development phase
49
Enrollment target
8
Study locations

NCT03025542 is a Phase 2 study of Chronic Plaque Psoriasis that has completed, run by UCB Biopharma SRL. The registered enrollment target is 49 participants, below the 1,124-participant average among 6 other Chronic Plaque Psoriasis trials with a reported enrollment target (96% lower). The trial reports 8 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03025542, a Phase 2 study of Chronic Plaque Psoriasis, has completed, sponsored by UCB Biopharma SRL.

COMPLETED
Registry status
Phase 2
Development phase
49 participants
Enrollment target
8
Study locations

Study Summary

This is a Phase 2a, multicenter, randomized, subject-blind, investigator-blind, study to investigate the pharmacokinetics (PK), pharmacodynamics (PD), and safety of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis

Conditions Studied

Chronic Plaque Psoriasis

Interventions

  • OTHER Placebo
  • DRUG Bimekizumab

Study Locations (8)

Other

  • Ps0016 102 - Kogarah
  • Ps0016 101 - Melbourne
  • Ps0016 104 - Woolloongabba
  • Ps0016 201 - Ajax
  • Ps0016 203 - London
  • Ps0016 202 - Windsor
  • Ps0016 501 - Chisinau

Ohio

  • Ps0016 704 - Bexley

Trial Details

FieldValue
Enrollment Target 49 participants
Start Date 2016-12-27
Est. Completion 2017-12-11
Phase Phase 2

Sponsor

UCB Biopharma SRL

82 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03025542

The ClinicalTrials.gov registry entry for NCT03025542 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 49 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,124-participant average among 6 other Chronic Plaque Psoriasis trials with a reported enrollment target (96% lower). The listed sponsor is UCB Biopharma SRL, which has 82 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Plaque Psoriasis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT03025542 reports 8 study locations spanning 2 distinct geographic areas - top geographies include Other, Ohio.

Frequently Asked Questions

What is clinical trial NCT03025542 about?

NCT03025542 is a clinical study titled "A Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of Bimekizumab in Patients With Chronic Plaque Psoriasis". This is a Phase 2a, multicenter, randomized, subject-blind, investigator-blind, study to investigate the pharmacokinetics (PK), pharmacodynamics (PD), and safety of bimekizumab in adult subjects with moderate to severe chronic plaque psoriasis

What is the current status of trial NCT03025542?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 49 participants. The study started on 2016-12-27. Estimated completion is 2017-12-11.

What conditions does trial NCT03025542 study?

This clinical trial studies the following conditions: Chronic Plaque Psoriasis.

What interventions are being tested in trial NCT03025542?

The interventions under investigation include: Placebo (OTHER), Bimekizumab (DRUG).

Who is sponsoring clinical trial NCT03025542?

This trial is sponsored by UCB Biopharma SRL, which has 82 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03025542 being conducted?

This trial has 8 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Plaque Psoriasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Plaque Psoriasis

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.